In 2022, Medcan became the first wellness provider in the country to enter the age of truly personalized medicine by providing whole genome sequencing to clients seeking the most advanced technology available to promote longevity. Now, a year later, who is getting their whole genome sequenced, and what impact has the decision had on their lives? What are some of the most surprising findings? Director of clinical innovation Allison Hazell (pictured above) leads director of genetics Jessica Gu and genetic counsellor Justin Lorentz in a fascinating discussion that also features CMO Dr. Peter Nord reflecting on his own experience getting his whole genome sequenced.

Genetic technology isn’t just for scientists anymore. We give genetic tests as gifts to our friends, our family, even our pets. Yet few people really understand what it is that a genetic counsellor does, or how clinical genetic testing works. Here, director of clinical innovation Allison Hazell (pictured above), clinical director of genetics Jessica Gu, and genetic counsellor Justin Lorentz answer the questions they get asked most.

Research into therapies for Alzheimer’s disease and dementia is progressing, and one day soon, those who are diagnosed early enough may be able to delay onset of the disease for so long that they never experience symptoms. So what’s happening at the forefront of Alzheimer’s research? What are the latest therapies, and how are doctors getting better at diagnosing it? What can we all do to reduce the risk of Alzheimer’s? Medcan senior medical consultant Dr. Lorne Greenspan checks in with clinical director of genetics Jessica Gu and Dr. Sharon Cohen of the Toronto Memory Program, a global expert on the disease (pictured above).